Anti-inflammatory cytokines directly inhibit innate but not adaptive CD8+ T cell functions

Journal of Virology

Volumn 88, Issue 13, 2014, Pages 7474-7484

  Freeman, Bailey E ^a,b   Meyer, Christine ^a,b   Slifka, Mark K ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; STAT3 PROTEIN; STAT6 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; MESSENGER RNA;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REGULATION; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INNATE IMMUNITY; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; UPREGULATION; VIRUS INFECTION; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; DRUG EFFECTS; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; INFLAMMATION; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADAPTIVE IMMUNITY; ANIMALS; BLOTTING, WESTERN; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; FLOW CYTOMETRY; IMMUNITY, INNATE; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 84902006241     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00658-14     Document Type: Article

References (42)

1. Berg RE, Cordes CJ, Forman J. 2002. Contribution of CD8+ T cells to innate immunity: IFN-gamma secretion induced by IL-12 and IL-18. Eur. J. Immunol. 32:2807-2816. http://dx.doi.org/10.1002/1521-4141 (2002010)32:10<2807::AID-IMMU2807>3.0.CO;2-0.
2. Lertmemongkolchai G, Cai G, Hunter CA, Bancroft GJ. 2001. Bystander activation of CD8+ T cells contributes to the rapid production of IFNgamma in response to bacterial pathogens. J. Immunol. 166:1097-1105. http://dx.doi.org/10.4049/jimmunol.166.2.1097.
3. Trinchieri G. 2003. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3:133-146. http://dx.doi.org /10.1038/nri1001.
4. Raue HP, Brien JD, Hammarlund E, Slifka MK. 2004. Activation of virus-specific CD8+ T cells by lipopolysaccharide-induced IL-12 and IL-18. J. Immunol. 173:6873-6881. http://dx.doi.org/10.4049/jimmunol.173 .11.6873.
5. Ingram JT, Yi JS, Zajac AJ. 2011. Exhausted CD8 T cells downregulate the IL-18 receptor and become unresponsive to inflammatory cytokines and bacterial co-infections. PLoS Pathog. 7:e1002273. http://dx.doi.org /10.1371/journal.ppat.1002273.
6. Chu T, Tyznik AJ, Roepke S, Berkley AM, Woodward-Davis A, Pattacini L, Bevan MJ, Zehn D, Prlic M. 2013. Bystander-activated memory CD8 T cells control early pathogen load in an innate-like, NKG2Ddependent manner. Cell Rep. 3:701-708. http://dx.doi.org/10.1016/j .celrep.2013.02.020.
7. Berg RE, Crossley E, Murray S, Forman J. 2003. Memory CD8+ T cells provide innate immune protection against Listeria monocytogenes in the absence of cognate antigen. J. Exp. Med. 198:1583-1593. http://dx.doi.org /10.1084/jem.20031051.
8. Nguyen KB, Biron CA. 1999. Synergism for cytokine-mediated disease during concurrent endotoxin and viral challenges: roles for NK and T cell IFN-gamma production. J. Immunol. 162:5238-5246.
9. Whitton JL, Slifka MK, Liu F, Nussbaum AK, Whitmire JK. 2004. The regulation and maturation of antiviral immune responses. Adv. Virus Res. 63:181-238. http://dx.doi.org/10.1016/S0065-3527(04)63003-X.
10. Khanolkar A, Fuller MJ, Zajac AJ. 2002. T cell responses to viral infections: lessons from lymphocytic choriomeningitis virus. Immunol. Res. 26:309-321. http://dx.doi.org/10.1385/IR:26:1-3:309.
11. Buchmeier MJ, Welsh RM, Dutko FJ, Oldstone MB. 1980. The virology and immunobiology of lymphocytic choriomeningitis virus infection. Adv. Immunol. 30:275-331. http://dx.doi.org/10.1016/S0065-2776(08) 60197-2.
12. Raue HP, Beadling C, Haun J, Slifka MK. 2013. Cytokine-mediated programmed proliferation of virus-specific CD8(+) memory T cells. Immunity 38:131-139. http://dx.doi.org/10.1016/j.immuni.2012.09.019.
13. Freeman BE, Hammarlund E, Raue HP, Slifka MK. 2012. Regulation of innate CD8+ T-cell activation mediated by cytokines. Proc. Natl. Acad. Sci. U. S. A. 109:9971-9976. http://dx.doi.org/10.1073/pnas.1203543109.
14. Beadling C, Slifka MK. 2006. Regulation of innate and adaptive immune responses by the related cytokines IL-12, IL-23, and IL-27. Arch. Immunol. Ther. Exp. (Warsz.) 54:15-24. http://dx.doi.org/10.1007/s00005-006-0002-6.
15. Ahn HJ, Maruo S, Tomura M, Mu J, Hamaoka T, Nakanishi K, Clark S, Kurimoto M, Okamura H, Fujiwara H. 1997. A mechanism underlying synergy between IL-12 and IFN-gamma-inducing factor in enhanced production of IFN-gamma. J. Immunol. 159:2125-2131.
16. Micallef MJ, Ohtsuki T, Kohno K, Tanabe F, Ushio S, Namba M, Tanimoto T, Torigoe K, Fujii M, Ikeda M, Fukuda S, Kurimoto M.1996. Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production. Eur. J. Immunol. 26:1647-1651. http: //dx.doi.org/10.1002/eji.1830260736.
17. Sad S, Li L, Mosmann TR. 1997. Cytokine-deficient CD8+ Tc1 cells induced by IL-4: retained inflammation and perforin and Fas cytotoxicity but compromised long term killing of tumor cells. J. Immunol. 159:606-613.
18. Sad S, Mosmann TR. 1995. Interleukin (IL) 4, in the absence of antigen stimulation, induces an anergy-like state in differentiated CD8+ TC1 cells: loss of IL-2 synthesis and autonomous proliferation but retention of cytotoxicity and synthesis of other cytokines. J. Exp. Med. 182:1505-1515. http://dx.doi.org/10.1084/jem.182.5.1505.
19. Oliver JA, Stolberg VR, Chensue SW, King PD. 2012. IL-4 acts as a potent stimulator of IFN-gamma expression in CD8+ T cells through STAT6-dependent and independent induction of Eomesodermin and Tbet. Cytokine 57:191-199. http://dx.doi.org/10.1016/j.cyto.2011.10.006.
20. Groux H, Bigler M, de Vries JE, Roncarolo MG. 1998. Inhibitory and stimulatory effects of IL-10 on human CD8+ T cells. J. Immunol. 160: 3188-3193.
21. Brooks DG, Ha SJ, Elsaesser H, Sharpe AH, Freeman GJ, Oldstone MB.2008. IL-10 and PD-L1 operate through distinct pathways to suppress T-cell activity during persistent viral infection. Proc. Natl. Acad. Sci. U. S. A. 105:20428-20433. http://dx.doi.org/10.1073/pnas.0811139106.
22. Brooks DG, Trifilo MJ, Edelmann KH, Teyton L, McGavern DB, Oldstone MB. 2006. Interleukin-10 determines viral clearance or persistence in vivo. Nat. Med. 12:1301-1309. http://dx.doi.org/10.1038 /nm1492.
23. Ejrnaes M, Filippi CM, Martinic MM, Ling EM, Togher LM, Crotty S, von Herrath MG. 2006. Resolution of a chronic viral infection after interleukin-10 receptor blockade. J. Exp. Med. 203:2461-2472. http://dx .doi.org/10.1084/jem.20061462.
24. Prochazkova J, Pokorna K, Holan V. 2012. IL-12 inhibits the TGF-betadependent T cell developmental programs and skews the TGF-betainduced differentiation into a Th1-like direction. Immunobiology 217: 74-82. http://dx.doi.org/10.1016/j.imbio.2011.07.032.
25. Blackburn SD, Wherry EJ. 2007. IL-10, T cell exhaustion and viral persistence. Trends Microbiol. 15:143-146. http://dx.doi.org/10.1016/j.tim .2007.02.006.
26. Schulz KR, Danna EA, Krutzik PO, Nolan GP. 2012. Single-cell phospho-protein analysis by flow cytometry. Curr. Protoc. Immunol. Chapter 8:Unit 8.17. http://dx.doi.org/10.1002/0471142735.im0817s78.
27. Krutzik PO, Clutter MR, Nolan GP. 2005. Coordinate analysis of murine immune cell surface markers and intracellular phosphoproteins by flow cytometry. J. Immunol. 175:2357-2365. http://dx.doi.org/10.4049 /jimmunol.175.4.2357.
28. Janeway CA, Jr, Medzhitov R. 2002. Innate immune recognition. Annu. Rev. Immunol. 20:197-216. http://dx.doi.org/10.1146/annurev.immunol .20.083001.084359.
29. Liu F, Whitton JL, Slifka MK. 2004. The rapidity with which virusspecific CD8+ T cells initiate IFN-gamma synthesis increases markedly over the course of infection and correlates with immunodominance. J. Immunol. 173:456-462. http://dx.doi.org/10.4049/jimmunol.173.1.456.
30. Rodriguez F, Slifka MK, Harkins S, Whitton JL. 2001. Two overlapping subdominant epitopes identified by DNA immunization induce protective CD8+ T-cell populations with differing cytolytic activities. J. Virol. 75:7399-7409. http://dx.doi.org/10.1128/JVI.75.16.7399-7409.2001.
31. Beadling C, Slifka MK. 2005. Differential regulation of virus-specific T-cell effector functions following activation by peptide or innate cytokines. Blood 105:1179-1186. http://dx.doi.org/10.1182/blood-2004-07-2833.
32. Hanlon AM, Jang S, Salgame P. 2002. Signaling from cytokine receptors that affect Th1 responses. Front. Biosci. 7:d1247-d1254. http://dx.doi.org /10.2741/hanlon.
33. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. 2001. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19:683-765. http://dx.doi.org/10.1146/annurev.immunol.19.1.683.
34. Smith KA. 1988. Interleukin-2: inception, impact, and implications. Science 240:1169-1176. http://dx.doi.org/10.1126/science.3131876.
35. Letourneau S, Krieg C, Pantaleo G, Boyman O. 2009. IL-2-and CD25-dependent immunoregulatory mechanisms in the homeostasis of T-cell subsets. J. Allergy Clin. Immunol. 123:758-762. http://dx.doi.org/10.1016 /j.jaci.2009.02.011.
36. Ziegler SF, Ramsdell F, Alderson MR. 1994. The activation antigen CD69. Stem Cells 12:456-465. http://dx.doi.org/10.1002/stem.55301 20502.
37. Shiow LR, Rosen DB, Brdickova N, Xu Y, An J, Lanier LL, Cyster JG, Matloubian M. 2006. CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 440: 540-544. http://dx.doi.org/10.1038/nature04606.
38. Feng C, Woodside KJ, Vance BA, El-Khoury D, Canelles M, Lee J, Gress R, Fowlkes BJ, Shores EW, Love PE. 2002. A potential role for CD69 in thymocyte emigration. Int. Immunol. 14:535-544. http://dx.doi.org/10 .1093/intimm/dxf020.
39. Carroll HP, Paunovic V, Gadina M. 2008. Signalling, inflammation and arthritis: crossed signals: the role of interleukin-15 and-18 in autoimmunity. Rheumatology (Oxford) 47:1269-1277. http://dx.doi.org/10.1093 /rheumatology/ken257.
40. Watford WT, Hissong BD, Bream JH, Kanno Y, Muul L, O'Shea JJ.2004. Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol. Rev. 202:139-156. http://dx.doi.org/10.1111/j.0105-2896.2004.00211.x.
41. Smith-Garvin JE, Koretzky GA, Jordan MS. 2009. T cell activation. Annu. Rev. Immunol. 27:591-619. http://dx.doi.org/10.1146/annurev .immunol.021908.132706.
42. Verdeil G, Chaix J, Schmitt-Verhulst AM, Auphan-Anezin N. 2006. Temporal cross-talk between TCR and STAT signals for CD8 T cell effector differentiation. Eur. J. Immunol. 36:3090-3100. http://dx.doi.org/10 .1002/eji.200636347.